HIV Testing in the Era of PrEP
Bernard M. Branson, MD
Director, Scientific Affairs LLC
Atlanta, GA
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2019. All rights reserved.
Dr. Bernard Branson has been involved with HIV testing for more than 30 years. He was the lead author of CDC’s 2006 revised recommendations for HIV screening in health care settings and, most recently, the June 2014 HIV testing recommendations that updated the U.S. laboratory HIV testing algorithm for the first time in 25 years. He is a graduate of the Northwestern University Feinberg School of Medicine and completed his postgraduate clinical training at the University of North Carolina at Chapel Hill. Dr. Branson joined the CDC in 1990 and served as Associate Director for Laboratory Diagnostics in CDC’s Division of HIV/AIDS Prevention for eleven years prior to his retirement in October 2014. Since then, Dr. Branson has provided expert consultation on HIV diagnostics, developed continuing medical education activities, and devoted his efforts to promoting the adoption of biomedical interventions such as treatment to achieve HIV viral suppression and pre-exposure prophylaxis.
At the completion of this educational session, learners will:
- Understand the new methods used to test for HIV antibody and antigen.
- Describe new estimates for the window period duration for different tests.
- Appreciate how treatment during early infection and PrEP can each affect HIV test results.
- Be aware of pending changes in FDA regulation of HIV tests and how it might affect access to new assays.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; and Merck & Co.
